ELAVL1 and hepatocellular carcinoma: It has been reported that ELAVL1 can suppress the expression of HK2 and pyruvate kinase-M2 (PKM2) by specifically binding to miR-199a precursor, consequently promoting the proliferation and growth of hepatocellular carcinoma(Zhang et al. 2015).